rs1175457710
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.2521delG(p.Asp841IlefsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.000000684 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.2521delG | p.Asp841IlefsTer6 | frameshift_variant | Exon 17 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:3
This sequence change creates a premature translational stop signal (p.Asp841Ilefs*6) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 9792409). This variant is also known as 2519delG. ClinVar contains an entry for this variant (Variation ID: 453419). For these reasons, this variant has been classified as Pathogenic. -
In the ATM gene (transcript: NM_000051) the heterozygous frame shift variant c.2521del; p.Asp841Ilefs*6 in exon 17 was detected. This variant was inherited from the mother. The germline variant leads to a shift in the reading frame and, after five incorrect amino acids, to a premature stop codon. This variant is not recorded in population-related databases. In the phenotype-related database LOVD it is listed once as pathogenic and once as a variant of unclear functional relevance, in HGMD it is classified as pathogenic and once as likely pathogenic and in ClinVar it is listed twice as pathogenic. The ACMG classification for this variant is: pathogenic (Class 5: PVS1, PM2, PM3, PP5). -
- -
not provided Pathogenic:3
- -
- -
- -
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.2521delG variant, located in coding exon 16 of the ATM gene, results from a deletion of one nucleotide at nucleotide position 2521, causing a translational frameshift with a predicted alternate stop codon (p.D841Ifs*6). This alteration, referred to as c.2519delG, was identified in conjunction with a second ATM alteration in an individual with features of ataxia telangiectasia (Broeks A et al. Hum. Mutat., 1998;12:330-7). This variant has also been identified in at least one patient with a personal and family history of breast and/or ovarian cancer (Maxwell KN et al. Am. J. Hum. Genet., 2016 May;98:801-817). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
This variant deletes 1 nucleotide in exon 17 of the ATM gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
See cases Pathogenic:1
ACMG categories: PVS1,PM2_sup,PM3 -
Familial cancer of breast Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at